pmc logo image
Logo of aacAntimicrob Agents Chemother SubscriptionsAntimicrob Agents Chemother Web Site

Formats:

Antimicrob Agents Chemother. 1974 October; 6(4): 411–414.
PMCID: PMC444661
Activity of Tetracycline, Doxycycline, and Minocycline Against Methicillin-Susceptible and -Resistant Staphylococci
J. N. Minuth, T. M. Holmes, and D. M. Musher
Department of Medicine, Veterans Administration Hospital, Houston, Texas 77031
Baylor College of Medicine, Houston, Texas 77025
Abstract
Tetracycline, doxycycline, and minocycline were evaluated for their antibacterial activity against methicillin-susceptible and -resistant isolates of Staphylococcus. At clinically achievable levels both doxycycline and minocycline were more active than tetracycline against methicillin-susceptible organisms. Tetracycline and doxycycline had no activity against methicillin-resistant staphylococci, whereas minocycline at 2 μg/ml inhibited six of 13 strains and, at 3 μg/ml, 10 of 13 strains.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (488K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Bach MC, Zinner SH, Wilcox C, Finland M. Efficacy of standard disc-diffusion test as applied to susceptibility of Staphylococcus aureus to tetracycline and minocycline. J Lab Clin Med. 1972 Feb;79(2):316–325. [PubMed]
  • Barrett FF, McGehee RF, Jr, Finland M. Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med. 1968 Aug 29;279(9):441–448. [PubMed]
  • Benner EJ, Kayser FH. Growing clinical significance of methcillin-resistant Staphylococcus aureus. Lancet. 1968 Oct 5;2(7571):741–744. [PubMed]
  • Bernard B, Yin EJ, Simon HJ. Clinical pharmacologic studies with minocycline. J Clin Pharmacol New Drugs. 1971 Sep–Oct;11(5):332–348. [PubMed]
  • Bulger RJ, Feigl P, Nielson K. Comparison of treatments with several antibiotics in experimental infections due to methicillin-resistant Staphylococcus aureus. J Infect Dis. 1972 Dec;126(6):674–678. [PubMed]
  • Carleton J, Phair JP. The slow bactericidal effect of tetracycline and minocycline on wall-defective staphylococcus. J Infect Dis. 1972 Oct;126(4):457–459. [PubMed]
  • Drew WL, Barry AL, O'Toole R, Sherris JC. Reliability of the Kirby-Bauer disc diffusion method for detecting methicillin-resistant strains of Staphylococcus aureus. Appl Microbiol. 1972 Aug;24(2):240–247. [PubMed]
  • Fedorko J, Katz S, Allnoch H. In vitro activity of minocycline, a new tetracycline. Am J Med Sci. 1968 Apr;255:252–258. [PubMed]
  • Klastersky J, Daneau D. Bacteriological evaluation of minocycline, a new tetracycline. Chemotherapy. 1972;17(1):51–58. [PubMed]
  • Leibowitz BJ, Hakes JL, Cahn MM, Levy EJ. Doxycycline blood levels in normal subjects after intravenous and oral administration. Curr Ther Res Clin Exp. 1972 Dec;14(12):820–832. [PubMed]
  • Lorian V. The mode of action of antibiotics on gram-negative bacilli. Arch Intern Med. 1971 Oct;128(4):623–632. [PubMed]
  • Macdonald H, Kelly RG, Allen ES, Noble JF, Kanegis LA. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther. 1973 Sep–Oct;14(5):852–861. [PubMed]
  • O'Toole RD, Drew WL, Dahlgren BJ, Beaty HN. An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA. 1970 Jul 13;213(2):257–263. [PubMed]
  • Steigbigel NH, Reed CW, Finland M. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro. Am J Med Sci. 1968 Mar;255:179–195. [PubMed]
  • Steigbigel NH, Reed CW, Finland M. Absorption and excretion of five tetracycline analogues in normal young men. Am J Med Sci. 1968 May;255:296–312. [PubMed]